相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。ASGR1 promotes liver injury in sepsis by modulating monocyte-to-macrophage differentiation via NF-xB/ATF5 pathway
Rui Shi et al.
LIFE SCIENCES (2023)
Inhibition of ASGR1 decreases lipid levels by promoting cholesterol excretion
Ju-Qiong Wang et al.
NATURE (2022)
Residual Cardiovascular Risk at Low LDL: Remnants, Lipoprotein(a), and Inflammation
Ron C. Hoogeveen et al.
CLINICAL CHEMISTRY (2021)
Fourth Universal Definition of Myocardial Infarction (2018)
Kristian Thygesen et al.
CIRCULATION (2018)
A genome-wide association study of essential hypertension in an Australian population using a DNA pooling approach
Javed Y. Fowdar et al.
MOLECULAR GENETICS AND GENOMICS (2017)
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
Brian A. Ference et al.
EUROPEAN HEART JOURNAL (2017)
Variant ASGR1 Associated with a Reduced Risk of Coronary Artery Disease
P. Nioi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
A Century of Cholesterol and Coronaries: From Plaques to Genes to Statins
Joseph L. Goldstein et al.
CELL (2015)
Galactose protects hepatocytes against TNF-α-induced apoptosis by promoting activation of the NF-κB signaling pathway in acute liver failure
Yanmin Liu et al.
LABORATORY INVESTIGATION (2015)
Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials
Jordan Fulcher et al.
LANCET (2015)
Effect of the Proprotein Convertase Subtilisin/Kexin 9 Monoclonal Antibody, AMG 145, in Homozygous Familial Hypercholesterolemia
Evan A. Stein et al.
CIRCULATION (2013)
Asialoglycoprotein receptor (ASGPR) as target autoantigen in liver autoimmunity: Lost and found
Eirini I. Rigopoulou et al.
AUTOIMMUNITY REVIEWS (2012)
Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20 536 high-risk individuals: a randomised controlled trial
R. Bulbulia et al.
LANCET (2011)
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
C. Baigent et al.
LANCET (2010)
A New Splice Variant of the Major Subunit of Human Asialoglycoprotein Receptor Encodes a Secreted Form in Hepatocytes
Jia Liu et al.
PLOS ONE (2010)
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
Erik von Elm et al.
LANCET (2007)
Overexpression of PCSK9 accelerates the degradation of the LDLR in a post-endoplasmic reticulum compartment
KN Maxwell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Statins upregulate PCSK9, the gene encoding the proprotein convertase neural apoptosis-regulated convertase-1 implicated in familial hypercholesterolemia
G Dubuc et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
分享论文
